Clinical trial registry record

CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT07443826
Last registry update
July 13, 2026
Status
Recruiting
Phase
PHASE1, PHASE2
Sponsor
Unlimited Biotechnology LLC
Enrollment
12
Countries
Honduras
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Gene therapy · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.